COO
Price
$76.70
Change
+$1.75 (+2.33%)
Updated
Jul 10 closing price
Capitalization
19.72B
47 days until earnings call
MTD
Price
$1236.24
Change
+$17.59 (+1.44%)
Updated
Jul 10 closing price
Capitalization
28.69B
20 days until earnings call
Interact to see
Advertisement

COO vs MTD

Header iconCOO vs MTD Comparison
Open Charts COO vs MTDBanner chart's image
Cooper Companies (The)
Price$76.70
Change+$1.75 (+2.33%)
Volume$2.98M
Capitalization19.72B
Mettler-Toledo International
Price$1236.24
Change+$17.59 (+1.44%)
Volume$157.88K
Capitalization28.69B
COO vs MTD Comparison Chart in %
Loading...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COO vs. MTD commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a StrongBuy and MTD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (COO: $76.70 vs. MTD: $1236.24)
Brand notoriety: COO and MTD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: COO: 109% vs. MTD: 85%
Market capitalization -- COO: $19.72B vs. MTD: $28.69B
COO [@Medical Specialties] is valued at $19.72B. MTD’s [@Medical Specialties] market capitalization is $28.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 0 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).

  • COO’s FA Score: 0 green, 5 red.
  • MTD’s FA Score: 1 green, 4 red.
According to our system of comparison, MTD is a better buy in the long-term than COO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 5 TA indicator(s) are bullish while MTD’s TA Score has 4 bullish TA indicator(s).

  • COO’s TA Score: 5 bullish, 4 bearish.
  • MTD’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MTD is a better buy in the short-term than COO.

Price Growth

COO (@Medical Specialties) experienced а +4.64% price change this week, while MTD (@Medical Specialties) price change was +2.25% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.22%. For the same industry, the average monthly price growth was +1.80%, and the average quarterly price growth was +1.36%.

Reported Earning Dates

COO is expected to report earnings on Aug 27, 2025.

MTD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (+2.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTD($28.7B) has a higher market cap than COO($19.7B). COO has higher P/E ratio than MTD: COO (68.09) vs MTD (37.36). MTD YTD gains are higher at: 1.026 vs. COO (-16.567). MTD has higher annual earnings (EBITDA): 1.17B vs. COO (895M). COO has more cash in the bank: 135M vs. MTD (69.8M). MTD has less debt than COO: MTD (2.08B) vs COO (2.77B). MTD (3.79B) and COO (3.67B) have equivalent revenues.
COOMTDCOO / MTD
Capitalization19.7B28.7B69%
EBITDA895M1.17B76%
Gain YTD-16.5671.026-1,614%
P/E Ratio68.0937.36182%
Revenue3.67B3.79B97%
Total Cash135M69.8M193%
Total Debt2.77B2.08B133%
FUNDAMENTALS RATINGS
COO vs MTD: Fundamental Ratings
COO
MTD
OUTLOOK RATING
1..100
2218
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
8956
SMR RATING
1..100
823
PRICE GROWTH RATING
1..100
6152
P/E GROWTH RATING
1..100
8375
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COO's Valuation (76) in the Medical Specialties industry is in the same range as MTD (98). This means that COO’s stock grew similarly to MTD’s over the last 12 months.

MTD's Profit vs Risk Rating (56) in the Medical Specialties industry is somewhat better than the same rating for COO (89). This means that MTD’s stock grew somewhat faster than COO’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is significantly better than the same rating for COO (82). This means that MTD’s stock grew significantly faster than COO’s over the last 12 months.

MTD's Price Growth Rating (52) in the Medical Specialties industry is in the same range as COO (61). This means that MTD’s stock grew similarly to COO’s over the last 12 months.

MTD's P/E Growth Rating (75) in the Medical Specialties industry is in the same range as COO (83). This means that MTD’s stock grew similarly to COO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COOMTD
RSI
ODDS (%)
Bearish Trend 1 day ago
46%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
59%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
62%
Advances
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
61%
Declines
ODDS (%)
Bearish Trend 29 days ago
57%
Bearish Trend 12 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
50%
Aroon
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BCDF31.250.14
+0.45%
Horizon Kinetics Blockchain Dev ETF
KYN12.430.05
+0.40%
Kayne Anderson Energy Infrastructure Fund
TSEC26.170.03
+0.11%
Touchstone Securitized Income ETF
QSPT29.72-0.02
-0.05%
FT Vest Nasdaq-100® Buffer ETF Sep
HYBX30.40-0.22
-0.72%
TCW High Yield Bond ETF

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with ALC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then ALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
+2.33%
ALC - COO
51%
Loosely correlated
+1.98%
A - COO
50%
Loosely correlated
+2.37%
DHR - COO
44%
Loosely correlated
+2.26%
MTD - COO
44%
Loosely correlated
+1.44%
WAT - COO
43%
Loosely correlated
+1.17%
More